Creative Medical Technology Holdings, Inc. entered into a Securities Purchase Agreement with its CEO, Timothy Warbington, for the purchase of one share of Series B Preferred Stock for $100. The company also filed a preliminary proxy statement for its upcoming annual meeting, which includes a proposal to increase the number of authorized shares of common stock.